| Dr Joshua Ben Rafoth, MD | |
|
4350 Towne Centre Dr, Suite 1000, Evans, GA 30809-3301 | |
| (706) 868-3940 | |
| Not Available |
| Full Name | Dr Joshua Ben Rafoth |
|---|---|
| Gender | Male |
| Speciality | Diagnostic Radiology |
| Experience | 21 Years |
| Location | 4350 Towne Centre Dr, Evans, Georgia |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1912050899 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2085R0202X | Radiology - Diagnostic Radiology | 057238 (Georgia) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| University Hospital | Augusta, GA | Hospital |
| Doctors Hospital | Augusta, GA | Hospital |
| Aiken Regional Medical Center | Aiken, SC | Hospital |
| Burke Medical Center | Waynesboro, GA | Hospital |
| University Mcduffie County Regional Medical Center | Thomson, GA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Stephen W Brown And Radiology Associates Of Augusta Llp | 0244293322 | 15 |
News Archive
Overweight children may be at higher risk of oesophageal (gullet) cancer when they grow up than their slimmer friends, according to research published this week in the British Journal of Cancer.
A new Cochrane review did not find clear evidence that taking zinc supplements reduces the occurrence of middle ear infections or otitis media in healthy children.
A research team from the Massachusetts Institute of Technology (MIT)-Harvard Center for Nanotechnology Excellence has custom-designed nanoparticles that can deliver the anticancer drug cisplatin specifically to prostate cancer cells.
Trius Therapeutics, Inc. has announced that it initiated its first Phase 1 clinical trial of TR-701, an antibacterial drug candidate intended for treatment of patients with serious Gram-positive bacterial infections, including those caused by MRSA and other drug-resistant strains.
› Verified 5 days ago
| Entity Name | Au Medical Associates Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1841230620 PECOS PAC ID: 9931013513 Enrollment ID: O20040107000188 |
News Archive
Overweight children may be at higher risk of oesophageal (gullet) cancer when they grow up than their slimmer friends, according to research published this week in the British Journal of Cancer.
A new Cochrane review did not find clear evidence that taking zinc supplements reduces the occurrence of middle ear infections or otitis media in healthy children.
A research team from the Massachusetts Institute of Technology (MIT)-Harvard Center for Nanotechnology Excellence has custom-designed nanoparticles that can deliver the anticancer drug cisplatin specifically to prostate cancer cells.
Trius Therapeutics, Inc. has announced that it initiated its first Phase 1 clinical trial of TR-701, an antibacterial drug candidate intended for treatment of patients with serious Gram-positive bacterial infections, including those caused by MRSA and other drug-resistant strains.
› Verified 5 days ago
| Entity Name | Stephen W Brown And Radiology Associates Of Augusta Llp |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1265540314 PECOS PAC ID: 0244293322 Enrollment ID: O20041109001146 |
News Archive
Overweight children may be at higher risk of oesophageal (gullet) cancer when they grow up than their slimmer friends, according to research published this week in the British Journal of Cancer.
A new Cochrane review did not find clear evidence that taking zinc supplements reduces the occurrence of middle ear infections or otitis media in healthy children.
A research team from the Massachusetts Institute of Technology (MIT)-Harvard Center for Nanotechnology Excellence has custom-designed nanoparticles that can deliver the anticancer drug cisplatin specifically to prostate cancer cells.
Trius Therapeutics, Inc. has announced that it initiated its first Phase 1 clinical trial of TR-701, an antibacterial drug candidate intended for treatment of patients with serious Gram-positive bacterial infections, including those caused by MRSA and other drug-resistant strains.
› Verified 5 days ago
| Entity Name | Au Health Imaging, Llc |
|---|---|
| Entity Type | Part B Supplier - Independent Diagnostic Testing Facility (idtf) |
| Entity Identifiers | NPI Number: 1487285193 PECOS PAC ID: 4688094105 Enrollment ID: O20201021001583 |
News Archive
Overweight children may be at higher risk of oesophageal (gullet) cancer when they grow up than their slimmer friends, according to research published this week in the British Journal of Cancer.
A new Cochrane review did not find clear evidence that taking zinc supplements reduces the occurrence of middle ear infections or otitis media in healthy children.
A research team from the Massachusetts Institute of Technology (MIT)-Harvard Center for Nanotechnology Excellence has custom-designed nanoparticles that can deliver the anticancer drug cisplatin specifically to prostate cancer cells.
Trius Therapeutics, Inc. has announced that it initiated its first Phase 1 clinical trial of TR-701, an antibacterial drug candidate intended for treatment of patients with serious Gram-positive bacterial infections, including those caused by MRSA and other drug-resistant strains.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Joshua Ben Rafoth, MD 1125 Troupe St, Augusta, GA 30904-4480 Ph: (706) 737-4275 | Dr Joshua Ben Rafoth, MD 4350 Towne Centre Dr, Suite 1000, Evans, GA 30809-3301 Ph: (706) 868-3940 |
News Archive
Overweight children may be at higher risk of oesophageal (gullet) cancer when they grow up than their slimmer friends, according to research published this week in the British Journal of Cancer.
A new Cochrane review did not find clear evidence that taking zinc supplements reduces the occurrence of middle ear infections or otitis media in healthy children.
A research team from the Massachusetts Institute of Technology (MIT)-Harvard Center for Nanotechnology Excellence has custom-designed nanoparticles that can deliver the anticancer drug cisplatin specifically to prostate cancer cells.
Trius Therapeutics, Inc. has announced that it initiated its first Phase 1 clinical trial of TR-701, an antibacterial drug candidate intended for treatment of patients with serious Gram-positive bacterial infections, including those caused by MRSA and other drug-resistant strains.
› Verified 5 days ago
Dr. William S Brooks Iii, M.D. Radiology Medicare: Not Enrolled in Medicare Practice Location: 4350 Towne Centre Dr, Suite 1000, Evans, GA 30809 Phone: 706-868-3940 | |
Dr. James Barry Davis, M.D. Radiology Medicare: Not Enrolled in Medicare Practice Location: 4350 Towne Centre Dr, Suite 1000, Evans, GA 30809 Phone: 706-868-3940 | |
Dr. Rodney Harold Hobbs Jr., MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 4350 Towne Centre Dr, Suite 1000, Evans, GA 30809 Phone: 706-868-3940 | |
Dr. William Kent Johnson, M.D. Radiology Medicare: Medicare Enrolled Practice Location: 4350 Towne Centre Dr, Suite 1000, Evans, GA 30809 Phone: 706-868-3940 | |
Dr. Harold Bradford Jones Jr., M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 4350 Towne Centre Dr, Suite 1000, Evans, GA 30809 Phone: 706-868-3940 | |
Dr. Christa Lynn Catalano, MD Radiology Medicare: Medicare Enrolled Practice Location: 515 Mckinnes Park, Evans, GA 30809 Phone: 706-210-7776 | |
Dr. Stuart H. Prather Iii, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 4350 Towne Centre Dr, Suite 1000, Evans, GA 30809 Phone: 706-868-3940 |